BLRX
Price
$3.47
Change
+$0.25 (+7.76%)
Updated
Apr 30 closing price
Capitalization
11.12M
20 days until earnings call
SNPX
Price
$2.43
Change
+$0.05 (+2.10%)
Updated
Apr 30 closing price
Capitalization
3.3M
Ad is loading...

BLRX vs SNPX

Header iconBLRX vs SNPX Comparison
Open Charts BLRX vs SNPXBanner chart's image
BioLineRx
Price$3.47
Change+$0.25 (+7.76%)
Volume$40.42K
Capitalization11.12M
Synaptogenix
Price$2.43
Change+$0.05 (+2.10%)
Volume$4.9K
Capitalization3.3M
BLRX vs SNPX Comparison Chart
Loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLRX vs. SNPX commentary
May 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a Buy and SNPX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 01, 2025
Stock price -- (BLRX: $3.47 vs. SNPX: $2.50)
Brand notoriety: BLRX and SNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 138% vs. SNPX: 57%
Market capitalization -- BLRX: $11.12M vs. SNPX: $3.3M
BLRX [@Biotechnology] is valued at $11.12M. SNPX’s [@Biotechnology] market capitalization is $3.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 1 FA rating(s) are green whileSNPX’s FA Score has 2 green FA rating(s).

  • BLRX’s FA Score: 1 green, 4 red.
  • SNPX’s FA Score: 2 green, 3 red.
According to our system of comparison, SNPX is a better buy in the long-term than BLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 4 TA indicator(s) are bullish.

  • BLRX’s TA Score: 4 bullish, 4 bearish.

Price Growth

BLRX (@Biotechnology) experienced а +15.67% price change this week, while SNPX (@Biotechnology) price change was +10.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.45%. For the same industry, the average monthly price growth was +5.12%, and the average quarterly price growth was -6.68%.

Reported Earning Dates

BLRX is expected to report earnings on May 21, 2025.

SNPX is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (+4.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLRX($11.1M) has a higher market cap than SNPX($3.3M). SNPX YTD gains are higher at: -27.977 vs. BLRX (-59.463). SNPX has higher annual earnings (EBITDA): -6.76M vs. BLRX (-13.32M). SNPX has more cash in the bank: 22.1M vs. BLRX (3.15M). BLRX has higher revenues than SNPX: BLRX (22M) vs SNPX (0).
BLRXSNPXBLRX / SNPX
Capitalization11.1M3.3M336%
EBITDA-13.32M-6.76M197%
Gain YTD-59.463-27.977213%
P/E RatioN/A2.75-
Revenue22M0-
Total Cash3.15M22.1M14%
Total Debt29.6MN/A-
FUNDAMENTALS RATINGS
BLRX: Fundamental Ratings
BLRX
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLRX
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNSP1.090.06
+5.34%
CNS Pharmaceuticals Inc.
BCYC8.550.34
+4.08%
Bicycle Therapeutics plc
SGMT3.450.03
+0.88%
Sagimet Biosciences
TMDX92.01-0.42
-0.45%
TransMedics Group
NTRA150.93-3.96
-2.56%
Natera

BLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with PYXS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
+7.76%
PYXS - BLRX
46%
Loosely correlated
+5.77%
KURA - BLRX
43%
Loosely correlated
+0.61%
DWTX - BLRX
33%
Loosely correlated
+1.29%
INSM - BLRX
30%
Poorly correlated
+0.87%
SNPX - BLRX
30%
Poorly correlated
+5.23%
More

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
+5.23%
NCNA - SNPX
92%
Closely correlated
+12.24%
RNAC - SNPX
91%
Closely correlated
+1.93%
AGEN - SNPX
91%
Closely correlated
-5.31%
ALLR - SNPX
87%
Closely correlated
+4.82%
NRXP - SNPX
84%
Closely correlated
+3.16%
More